FDA Approved: ADENOSINE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved Mylan Institutional LLC's original ANDA for Adenosine, a generic short-acting antiarrhythmic. The approval supports the generic's use for terminati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Supraventricular Tachycardia

Drugs mentioned

• Adenosine (Adenosine)

Snippet

ORIG AP for ADENOSINE (ADENOSINE)